lobbying_activities: 2152743

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
2152743	b6646789-5c84-4ae7-a86a-ac7481daaff8	Q2	BUCHANAN INGERSOLL & ROONEY PC	55291	ANI PHARMACEUTICALS, INC.	2018	second_quarter	PHA	Federal government relations service, strategy development and implementation relating to status of FDAs action with regards to the companys NDA.	Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE	30000		0	0	2018-07-19T05:51:08.167000-04:00